Endonovo Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ENDV for the last quarter is 1.66 k USD, and it's 80.18% lower compared to the previous quarter. The net income of Q2 24 is -721.29 k USD.